Strategic Investment Solutions’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.4K Hold
192
﹤0.01% 379
2026
Q1
$15.4K Hold
192
﹤0.01% 374
2025
Q4
$16.4K Hold
192
﹤0.01% 338
2025
Q3
$14.9K Hold
192
﹤0.01% 329
2025
Q2
$15K Hold
192
﹤0.01% 310
2025
Q1
$13.9K Hold
192
﹤0.01% 331
2024
Q4
$14.2K Hold
192
﹤0.01% 346
2024
Q3
$12.7K Hold
192
﹤0.01% 335
2024
Q2
$12.1K Buy
+192
New +$17K ﹤0.01% 329
2023
Q4
$15.5K Sell
203
-11,893
-98% -$828K ﹤0.01% 693
2023
Q3
$972K Buy
12,096
+11,904
+6,200% +$957K 0.01% 319
2023
Q2
$16.4K Hold
192
﹤0.01% 493
2023
Q1
$15.9K Buy
+192
New +$15.1K ﹤0.01% 569

Other funds holding EW

Strategic Investment Solutions's EW Position: Q2 2026 in Review

Strategic Investment Solutions held its Edwards Lifesciences (EW) position steady in Q2 2026 at 192 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #379.

Strategic Investment Solutions first reported a position in EW in Q1 2023 and has held it in 13 quarters since. The position peaked at $972K in Q3 2023. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Strategic Investment Solutions held 192 shares of Edwards Lifesciences worth $17.4K as of Q2 2026.
  • Strategic Investment Solutions left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Strategic Investment Solutions's portfolio in Q2 2026, its #379 holding.
  • Strategic Investment Solutions first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 13 quarters since.
  • Strategic Investment Solutions's Edwards Lifesciences position peaked at $972K in Q3 2023.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.